作者:David C. Pryde、Brian E. Marron、Christopher W. West、Steven Reister、George Amato、Katrina Yoger、Brett Antonio、Karen Padilla、Peter J. Cox、Jamie Turner、Joseph S. Warmus、Nigel A. Swain、Kiyoyuki Omoto、John H. Mahoney、Aaron C. Gerlach
DOI:10.1021/acsmedchemlett.7b00140
日期:2017.6.8
A series of TRPA1 antagonists is described which has as its core structure an indazole moiety. The physical properties and in vitro DMPK profiles are discussed. Good in vivo exposure was obtained with several analogs, allowing efficacy to be assessed in rodent models of inflammatory pain. Two compounds showed significant activity in these models when administered either systemically or topically. Protein
描述了一系列具有吲唑部分作为其核心结构的TRPA1拮抗剂。讨论了物理特性和体外DMPK曲线。用几种类似物获得了良好的体内暴露,从而可以在啮齿动物炎性疼痛模型中评估功效。当全身或局部给药时,两种化合物在这些模型中显示出显着的活性。构建蛋白质嵌合体以指示来自结合在通道S5区域中的序列的化合物,并且使用计算对接模型来提出例如化合物的结合模式。